Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|June 15, 2024
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE studyAngelica Barone, Annalisa Chiappella, Beatrice Casadei, et al.
American Journal of Hematology|November 4, 2020
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimenPatrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2021
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantationNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
Bone Marrow Transplantation|October 16, 2025
Impact of Wilms' tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registryArnon Nagler, Jordi Esteve, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy|June 20, 2025
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative StudyCorrado Tarella, Simona Sammassimo, Samuele Frassoni, et al.
Frontiers in Immunology|December 27, 2023
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Bone Marrow Transplantation|March 24, 2020
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-BegelomabAndrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, et al.
Blood Advances|August 5, 2025
Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysisAnna Dodero, Giusy Ceparano, Beatrice Casadei, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
American Journal of Hematology|August 29, 2025
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMTJuan Carlos Hernández-Boluda, Vipul Sheth, Simona Iacobelli, et al.
Pageof 20